Hurwitz A, Looney G, Sullins M, Ben-Zvi Z
Department of Internal Medicine, University of Kansas Medical Center, Kansas City 66103.
Hepatology. 1990 Dec;12(6):1406-12. doi: 10.1002/hep.1840120623.
Morphine slows hepatobiliary elimination of sulfobromophthalein in rodents, raising dye levels in plasma and liver. Earlier studies showed these effects to be independent of other opiate effects such as bile duct spasm, hypothermia or blood gas changes resulting from respiratory depression. Because opiate receptors are distributed throughout the body, within the central nervous system and at peripheral sites including the gastrointestinal tract, experiments were performed to ascertain whether central or peripheral sites mediate the hepatobiliary effects of morphine. Sulfobromophthalein was administered intravenously to mice and its levels were measured in plasma and liver. Tail-flick latency indicated centrally mediated analgesia. Inhibited intestinal transit of India ink reflected an opiate effect with a significant peripheral component. When injected into a cerebral ventricle morphine was much more potent in producing analgesia and raising sulfobromophthalein levels than when administered intravenously or intraperitoneally. An intravenous dose of naloxone that reversed morphine analgesia also prevented sulfobromophthalein elevation but did not prevent gut slowing. Naltrexone injected in a cerebral ventricle also reversed analgesia and sulfobromophthalein elevation but not intestinal slowing. The polar opiate agonist N-methylmorphine did not cause analgesia or raise sulfobromophthalein levels at peripheral intraperitoneal doses to 100 mg/kg. When given in a central ventricle at 4 x 10(-3) mg/kg, this agent produced analgesia and raised sulfobromophthalein but did not slow intestinal transit. After spinal cord transection, intravenous morphine did not retard the tail-flick response or affect sulfobromophthalein disposition, but peripherally mediated intestinal transit was slowed as it was in intact mice. These experiments demonstrate parallel opiate effects on analgesia and on BSP disposition but not on intestinal transit.(ABSTRACT TRUNCATED AT 250 WORDS)
吗啡会减缓啮齿动物体内磺溴酞钠的肝胆清除过程,使血浆和肝脏中的染料水平升高。早期研究表明,这些作用独立于其他阿片类药物的作用,如胆管痉挛、体温过低或呼吸抑制导致的血气变化。由于阿片受体分布于全身,包括中枢神经系统以及胃肠道等外周部位,因此进行了实验以确定是中枢还是外周部位介导了吗啡的肝胆效应。给小鼠静脉注射磺溴酞钠,并测量其在血浆和肝脏中的水平。甩尾潜伏期表明存在中枢介导的镇痛作用。印度墨汁在肠道内的转运受抑制反映了阿片类药物的一种具有显著外周成分的效应。当注入脑室时,吗啡产生镇痛作用和提高磺溴酞钠水平的效力比静脉注射或腹腔注射时要强得多。静脉注射一剂能逆转吗啡镇痛作用的纳洛酮也能防止磺溴酞钠水平升高,但不能防止肠道蠕动减慢。注入脑室的纳曲酮也能逆转镇痛作用和磺溴酞钠水平升高,但不能逆转肠道蠕动减慢。极性阿片激动剂N - 甲基吗啡在腹腔注射剂量达100 mg/kg时,在外周不会引起镇痛作用或提高磺溴酞钠水平。当以4×10⁻³ mg/kg的剂量注入脑室时,该药物产生镇痛作用并提高磺溴酞钠水平,但不会减缓肠道蠕动。脊髓横断后,静脉注射吗啡不会延迟甩尾反应或影响磺溴酞钠的处置,但外周介导的肠道蠕动会像在完整小鼠中一样减慢。这些实验证明了阿片类药物对镇痛作用和磺溴酞钠处置具有平行效应,但对肠道蠕动没有影响。(摘要截短于250字)